The healthcare burden and associated adverse events from total alloplastic temporomandibular joint replacement: a national United States perspective.

TMJ surgery adverse event complication cost end-stage TMJ disease length of hospital stay temporomandibular joint temporomandibular joint reconstruction temporomandibular joint replacement total alloplastic temporomandibular joint prosthesis

Journal

International journal of oral and maxillofacial surgery
ISSN: 1399-0020
Titre abrégé: Int J Oral Maxillofac Surg
Pays: Denmark
ID NLM: 8605826

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 06 05 2020
revised: 09 06 2020
accepted: 11 08 2020
pubmed: 13 9 2020
medline: 28 1 2021
entrez: 12 9 2020
Statut: ppublish

Résumé

The purpose of this study was to provide a United States perspective on alloplastic total joint replacement. We sought to estimate the inpatient burden and report the most common adverse events using two administrative datasets. The National Inpatient Sample was queried from October 2015 to December 2016 for total joint replacement admissions using International Classification of Diseases 10

Identifiants

pubmed: 32917485
pii: S0901-5027(20)30301-5
doi: 10.1016/j.ijom.2020.08.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

236-241

Informations de copyright

Copyright © 2020 International Association of Oral and Maxillofacial Surgeons. All rights reserved.

Auteurs

Kevin C Lee (KC)

Columbia University Medical Center, New York, NY, USA.

Nikita Chintalapudi (N)

Columbia University Medical Center, New York, NY, USA.

Steven Halepas (S)

Columbia University Medical Center, New York, NY, USA.

Sung-Kiang Chuang (SK)

Deparment of Oral and Maxillofacial Surgery, University of Pennsylvania, Philadelphia, PA, USA.

Firat Selvi (F)

Department of Oral and Maxillofacial Surgery, Istanbul University, School of Dentistry, Beyazit, Istanbul, Turkey. Electronic address: fselvi@istanbul.edu.tr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH